APOE and Alzheimer disease: Of the proteins described in Table 3 we selected APOE (approach A), NDP (approach B), HTRA1, APSC and COL6A2 (approach C), based on the fold change or specific expression in the CAA type-1 group compared to the AD and control groups, to confirm our mass spectrometry results.